Aqualung Therapeutics has developed a first in man novel humanized monoclonal antibody (mAb eNamptor) targeting inflammation. We intend to treat conditions such as Acute Respiratory Distress Syndrome,Prostate Cancer and Chorioamnionitis (which leads to premature birth.)



View Details...